HLA-C and skin disorder: As CD1a signaling is implicated in common inflammatory skin disorders, the mitigating effect of anandamide on CD1a expression holds promise to selectively dampen inflammation induced by CD1a restricted T cells, without impacting systemic immune responses as antigen presentation through the MHC pathway is not impacted in a negative way.